Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BE-RELACs Trial: Biomarkers Explaining Relevance of Acute Rejections
2012-001352-19Phase 4Completed
- Sponsor
- Medizinische Hochschule Hannover
- Start
- Aug 2012
- Modality
- Small Molecules, Peptides, Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial in kidney allograft rejection and kidney transplant comparing Belatacept (Nulojix) arm with Cyclosporine arm (2 arms). Started Aug 2012; status: completed.
02
Drugs
belataceptcyclosporine
03
Conditions
kidney allograft rejectionkidney transplant
Beyond the preview
Go deeper on 2012-001352-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001352-19.